×
AMNEAL PHARMACEUTICALS, INC Common Stock Net 2010-2025 | AMRX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
AMNEAL PHARMACEUTICALS, INC common stock net from 2010 to 2025. Common stock net can be defined as the value of common equity ownership.
View More
AMNEAL PHARMACEUTICALS, INC Common Stock Net 2010-2025 | AMRX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
AMNEAL PHARMACEUTICALS, INC common stock net from 2010 to 2025. Common stock net can be defined as the value of common equity ownership.
Related Stocks
Company Name
Market
Cap
Chugai Pharmaceutical (CHGCY)
$75.9B
Zoetis (ZTS)
$67.3B
Takeda Pharmaceutical (TAK)
$46.3B
Daiichi Sankyo, - (DSNKY)
$45.5B
BeOne Medicines - (ONC)
$32.4B
Sandoz Group AG (SDZNY)
$25.8B
Summit Therapeutics (SMMT)
$19.7B
Merck (MKKGY)
$16.7B
Shionogi (SGIOY)
$14B
United Therapeutics (UTHR)
$13.4B
Neurocrine Biosciences (NBIX)
$13.1B
Orion OYJ (ORINY)
$11.7B
IPSEN (IPSEY)
$10.3B
Stevanato Group S.p.A (STVN)
$7.4B
Corcept Therapeutics (CORT)
$7.3B
Madrigal Pharmaceuticals (MDGL)
$7B
Ionis Pharmaceuticals (IONS)
$6.7B
Grifols, S.A (GRFS)
$6.6B
Hikma Pharmaceuticals Plc (HKMPF)
$6.2B
Ono Pharmaceutical (OPHLF)
$5.2B
Soleno Therapeutics (SLNO)
$4.3B
Procaps Group, S.A (PROCF)
$3.2B
Hypermarcas (HYPMY)
$3B
Crinetics Pharmaceuticals (CRNX)
$2.9B
NewAmsterdam Pharma (NAMS)
$2.6B
Catalyst Pharmaceuticals (CPRX)
$2.5B
Centessa Pharmaceuticals (CNTA)
$2.2B
Ocular Therapeutix (OCUL)
$1.8B
BioCryst Pharmaceuticals (BCRX)
$1.8B
ARS Pharmaceuticals (SPRY)
$1.7B